The Great Substitution: Why Investors Are Skipping Bonds For Dividend Stocks

2026-02-06 08:30:00 ET

Like many investors, I manage my wealth across different accounts with distinct goals. Most of my coverage on Seeking Alpha focuses on biotech, where I follow Peter Lynch's , advice to "buy what you understand." Since biotech is a growth sector, my IRA is positioned for aggressive capital appreciation. At 44, I have a 15-year time horizon that I cannot touch those funds - a perfect period to seek aggressive growth in an industry I understand....

Read the full article on Seeking Alpha

For further details see: